These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 22772053

  • 1. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy.
    Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Wranicz JK.
    Europace; 2013 Jan; 15(1):116-21. PubMed ID: 22772053
    [Abstract] [Full Text] [Related]

  • 2. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia.
    Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Cygankiewicz I, Wranicz JK.
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):338-44. PubMed ID: 23426376
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ivabradine in patients with inappropriate sinus tachycardia.
    Zellerhoff S, Hinterseer M, Felix Krull B, Schulze-Bahr E, Fabritz L, Breithardt G, Kirchhof P, Kääb S.
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Dec; 382(5-6):483-6. PubMed ID: 20859616
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Control of cardiac chronotropic function in patients after heart transplantation: effects of ivabradine and metoprolol succinate on resting heart rate in the denervated heart.
    Rivinius R, Helmschrott M, Ruhparwar A, Rahm AK, Darche FF, Thomas D, Bruckner T, Ehlermann P, Katus HA, Doesch AO.
    Clin Res Cardiol; 2018 Feb; 107(2):138-147. PubMed ID: 29098378
    [Abstract] [Full Text] [Related]

  • 10. Treatment of inappropriate sinus tachycardia with ivabradine.
    Annamaria M, Lupo PP, Foresti S, De Ambroggi G, de Ruvo E, Sciarra L, Cappato R, Calo L.
    J Interv Card Electrophysiol; 2016 Jun; 46(1):47-53. PubMed ID: 26467151
    [Abstract] [Full Text] [Related]

  • 11. Inappropriate sinus tachycardia: focus on ivabradine.
    Abed HS, Fulcher JR, Kilborn MJ, Keech AC.
    Intern Med J; 2016 Aug; 46(8):875-83. PubMed ID: 27059112
    [Abstract] [Full Text] [Related]

  • 12. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO, Celik S, Ehlermann P, Frankenstein L, Zehelein J, Koch A, Katus HA, Dengler TJ.
    Transplantation; 2007 Oct 27; 84(8):988-96. PubMed ID: 17989604
    [Abstract] [Full Text] [Related]

  • 13. Treatment of inappropriate sinus tachycardia with ivabradine.
    Rakovec P.
    Wien Klin Wochenschr; 2009 Oct 27; 121(21-22):715-8. PubMed ID: 19998013
    [Abstract] [Full Text] [Related]

  • 14. Comparative effectiveness of metoprolol, ivabradine, and its combination in the management of inappropriate sinus tachycardia in coronary artery bypass graft patients.
    Bhatt P, Bhavsar N, Naik D, Shah D.
    Indian J Pharmacol; 2021 Oct 27; 53(4):264-269. PubMed ID: 34414903
    [Abstract] [Full Text] [Related]

  • 15. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
    Majewski S, Slomka S, Zielinska-Wyderkiewicz E, Ciebiada M, Gorski P.
    Am J Cardiovasc Drugs; 2012 Jun 01; 12(3):179-88. PubMed ID: 22409211
    [Abstract] [Full Text] [Related]

  • 16. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation.
    Cappato R, Castelvecchio S, Ricci C, Bianco E, Vitali-Serdoz L, Gnecchi-Ruscone T, Pittalis M, De Ambroggi L, Baruscotti M, Gaeta M, Furlanello F, Di Francesco D, Lupo PP.
    J Am Coll Cardiol; 2012 Oct 09; 60(15):1323-9. PubMed ID: 22981555
    [Abstract] [Full Text] [Related]

  • 17. Ivabradine for the prevention of inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator.
    Adler A, Rosso R, Meir I, Viskin S.
    Europace; 2013 Mar 09; 15(3):362-5. PubMed ID: 23118003
    [Abstract] [Full Text] [Related]

  • 18. Ivabradine for inappropriate sinus tachycardia: another piece of evidence.
    Wichterle D.
    Europace; 2013 Jan 09; 15(1):9-10. PubMed ID: 22927663
    [No Abstract] [Full Text] [Related]

  • 19. Baseline intrinsic heart rate and response to ivabradine treatment in patients with inappropriate sinus tachycardia.
    Kaczmarek K, Klingenheben T, Poddebska I, Urbanek I, Wranicz JK, Cygankiewicz I, Ptaszyński P.
    Ann Noninvasive Electrocardiol; 2020 May 09; 25(3):e12709. PubMed ID: 31595620
    [Abstract] [Full Text] [Related]

  • 20. Inappropriate sinus tachycardia-symptom and heart rate reduction with ivabradine: A pooled analysis of prospective studies.
    Mathew ST, Po SS, Thadani U.
    Heart Rhythm; 2018 Feb 09; 15(2):240-247. PubMed ID: 29017929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.